Literature DB >> 21749879

CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation.

Seema Singh1, Sheng Wu, Michelle Varney, Ajay P Singh, Rakesh K Singh.   

Abstract

CXCR1 and CXCR2 are receptors for angiogenic ELR+CXC chemokines and are differentially expressed on endothelial cells; however, their functional significance in angiogenesis remains unclear. In this study, we determined the functional significance of these receptors in modulating endothelial cell phenotype by knocking-down the expression of CXCR1 and/or CXCR2 in human microvascular endothelial cells (HMEC-1) using short-hairpin RNA (shRNA). Cell proliferation, migration, invasion and capillary-like structure (CLS) formation were analyzed. Our data demonstrate that knock-down of CXCR1 and/or CXCR2 expression inhibited endothelial cell proliferation, survival, migration, invasion and CLS formation. Additionally, we examined the mechanism of CXCL8-dependent CXCR1 and/or CXCR2 mediated phenotypic changes by evaluating ERK phosphorylation and cytoskeletal rearrangement and observed inhibition of ERK phosphorylation and cytoskeletal rearrangement in HMEC-1-shCXCR1, HMEC-1-shCXCR2 and HMEC-1-shCXCR1/2 cells. Together, these data demonstrate that CXCR1 and CXCR2 expression plays a critical role in regulating multiple biological activities in human microvascular endothelial cells.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21749879      PMCID: PMC3215896          DOI: 10.1016/j.mvr.2011.06.011

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  53 in total

1.  Chemokines: not just leukocyte chemoattractants in the promotion of cancer.

Authors:  R M Strieter
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

Review 2.  International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature.

Authors:  Philip M Murphy
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

3.  Interleukin-8-induced proliferation, survival, and MMP production in CXCR1 and CXCR2 expressing human umbilical vein endothelial cells.

Authors:  Aihua Li; Seema Dubey; Michelle L Varney; Rakesh K Singh
Journal:  Microvasc Res       Date:  2002-11       Impact factor: 3.514

4.  Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells.

Authors:  R Salcedo; J H Resau; D Halverson; E A Hudson; M Dambach; D Powell; K Wasserman; J J Oppenheim
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

5.  Shear stress induces interleukin-8 mRNA expression and transcriptional activation in human vascular endothelial cells.

Authors:  Feng Liang; Ning Huang; Boyao Wang; Huaiqing Chen; Lizhi Wu
Journal:  Chin Med J (Engl)       Date:  2002-12       Impact factor: 2.628

6.  Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma.

Authors:  R Masood; J Cai; A Tulpule; T Zheng; A Hamilton; S Sharma; B M Espina; D L Smith; P S Gill
Journal:  Clin Cancer Res       Date:  2001-09       Impact factor: 12.531

7.  Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials.

Authors:  A Li; M L Varney; R K Singh
Journal:  Clin Cancer Res       Date:  2001-10       Impact factor: 12.531

8.  Pro-inflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2.

Authors:  Nathalie Vadeboncoeur; Mariela Segura; Dina Al-Numani; Ghyslaine Vanier; Marcelo Gottschalk
Journal:  FEMS Immunol Med Microbiol       Date:  2003-01-21

Review 9.  A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

Authors:  Keiran S M Smalley
Journal:  Int J Cancer       Date:  2003-05-01       Impact factor: 7.396

10.  Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2.

Authors:  Jan Heidemann; Hitoshi Ogawa; Michael B Dwinell; Parvaneh Rafiee; Christian Maaser; Henning R Gockel; Mary F Otterson; David M Ota; Norbert Lugering; Wolfram Domschke; David G Binion
Journal:  J Biol Chem       Date:  2002-12-20       Impact factor: 5.157

View more
  27 in total

Review 1.  The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions.

Authors:  Antonio Citro; Elisa Cantarelli; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

Review 2.  Chemokines, chemokine receptors and the gastrointestinal system.

Authors:  Hiroshi Miyazaki; Kazuaki Takabe; W Andrew Yeudall
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

3.  The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and Chemokines.

Authors:  Adit Ben-Baruch
Journal:  Cancer Microenviron       Date:  2011-12-22

4.  Host Cxcr2-dependent regulation of mammary tumor growth and metastasis.

Authors:  Bhawna Sharma; Kalyan C Nannuru; Michelle L Varney; Rakesh K Singh
Journal:  Clin Exp Metastasis       Date:  2014-12-16       Impact factor: 5.150

Review 5.  The role of CXC chemokines and their receptors in the progression and treatment of tumors.

Authors:  Qingchao Zhu; Xiaodong Han; Jiayuan Peng; Huanlong Qin; Yu Wang
Journal:  J Mol Histol       Date:  2012-06-30       Impact factor: 2.611

Review 6.  CXCR2: a target for pancreatic cancer treatment?

Authors:  Kathleen M Hertzer; Graham W Donald; O Joe Hines
Journal:  Expert Opin Ther Targets       Date:  2013-02-21       Impact factor: 6.902

7.  Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma.

Authors:  Chris W D Armstrong; Jonathan A Coulter; Chee Wee Ong; Pamela J Maxwell; Steven Walker; Karl T Butterworth; Oksana Lyubomska; Silvia Berlingeri; Rebecca Gallagher; Joe M O'Sullivan; Suneil Jain; Ian G Mills; Kevin M Prise; Robert G Bristow; Melissa J LaBonte; David J J Waugh
Journal:  NAR Cancer       Date:  2020-07-03

8.  Lipopolysaccharide activates Toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway and proinflammatory response in human pericytes.

Authors:  Irene Guijarro-Muñoz; Marta Compte; Ana Álvarez-Cienfuegos; Luis Álvarez-Vallina; Laura Sanz
Journal:  J Biol Chem       Date:  2013-12-04       Impact factor: 5.157

9.  IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells.

Authors:  Masahiro Shimizu; Nobuyuki Tanaka
Journal:  Oncogene       Date:  2018-10-10       Impact factor: 9.867

Review 10.  Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity.

Authors:  Sugandha Saxena; Rakesh K Singh
Journal:  Cancer Metastasis Rev       Date:  2021-05-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.